Dianthus Therapeutics
DNTH
DNTH
70 hedge funds and large institutions have $419M invested in Dianthus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+7
Holders Change %
+11.11%
% of All Funds
1.52%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
17
Increased
25
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$34.6M |
| 2 |
BlackRock
New York
|
+$7.2M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$6.18M |
| 4 |
Alkeon Capital Management
New York
|
+$5.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.61M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$21M |
| 2 |
AG
Artal Group
Luxembourg
|
-$2.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$880K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$659K |
| 5 |
SIM
Spark Investment Management
New York
|
-$408K |
